Cargando…
Efficient Prostate Cancer Therapy with Tissue-Specific Homing Peptides Identified by Advanced Phage Display Technology
Selective targeting of drugs to tumor cells is a key goal in oncology. Here, we performed an in vivo phage display to identify peptides that specifically target xenografted prostate cancer cells. This yielded three peptide candidates, LN1 (C-TGTPARQ-C), LN2 (C-KNSMFAT-C), and LN3 (C-TNKHSPK-C); each...
Autores principales: | Wada, Akinori, Terashima, Tomoya, Kageyama, Susumu, Yoshida, Tetsuya, Narita, Mitsuhiro, Kawauchi, Akihiro, Kojima, Hideto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369249/ https://www.ncbi.nlm.nih.gov/pubmed/30788426 http://dx.doi.org/10.1016/j.omto.2019.01.001 |
Ejemplares similares
-
Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report
por: Kubota, Shigehisa, et al.
Publicado: (2021) -
Androgen receptor axis-targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer
por: Wada, Akinori, et al.
Publicado: (2022) -
Metastatic Prostatic Ductal Adenocarcinoma Successfully Treated with Docetaxel Chemotherapy: A Case Report
por: Fujiwara, Ryo, et al.
Publicado: (2015) -
Prognostic nutritional index of early post-pembrolizumab therapy predicts long-term survival in patients with advanced urothelial carcinoma
por: Kageyama, Susumu, et al.
Publicado: (2022) -
Population‑based prostate‑specific antigen screening for prostate cancer may have an indirect effect on early detection through opportunistic testing in Kusatsu City, Shiga, Japan
por: Kageyama, Susumu, et al.
Publicado: (2022)